183 related articles for article (PubMed ID: 22839505)
21. The CD44+/CD24- phenotype is enriched in basal-like breast tumors.
Honeth G; Bendahl PO; Ringnér M; Saal LH; Gruvberger-Saal SK; Lövgren K; Grabau D; Fernö M; Borg A; Hegardt C
Breast Cancer Res; 2008; 10(3):R53. PubMed ID: 18559090
[TBL] [Abstract][Full Text] [Related]
22. CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma.
Lin Y; Zhong Y; Guan H; Zhang X; Sun Q
J Exp Clin Cancer Res; 2012 Jul; 31(1):59. PubMed ID: 22762532
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of CD24 and CD44 in breast cancer: a meta-analysis.
Wang Z; Wang Q; Wang Q; Wang Y; Chen J
Int J Biol Markers; 2017 Mar; 32(1):e75-e82. PubMed ID: 27470135
[TBL] [Abstract][Full Text] [Related]
24. The role of CD44+/CD24-/low biomarker for screening, diagnosis and monitoring of breast cancer.
Camerlingo R; Ferraro GA; De Francesco F; Romano M; Nicoletti G; Di Bonito M; Rinaldo M; D'Andrea F; Pirozzi G
Oncol Rep; 2014 Mar; 31(3):1127-32. PubMed ID: 24366074
[TBL] [Abstract][Full Text] [Related]
25. Histological and prognostic importance of CD44(+) /CD24(+) /EpCAM(+) expression in clinical pancreatic cancer.
Ohara Y; Oda T; Sugano M; Hashimoto S; Enomoto T; Yamada K; Akashi Y; Miyamoto R; Kobayashi A; Fukunaga K; Morishita Y; Ohkohchi N
Cancer Sci; 2013 Aug; 104(8):1127-34. PubMed ID: 23679813
[TBL] [Abstract][Full Text] [Related]
26. Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.
Xu GF; Zhang WJ; Sun Q; Xu X; Zou X; Guan W
World J Surg Oncol; 2014 Dec; 12():368. PubMed ID: 25441488
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of Cyclin D1 and CD44 Expression in Gastric Adenocarcinoma.
Ibrahim HM; AbdElbary AM; Mohamed SY; Elwan A; Abdelhamid MI; Ibrahim A
J Gastrointest Cancer; 2019 Sep; 50(3):370-379. PubMed ID: 29497929
[TBL] [Abstract][Full Text] [Related]
28. Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity.
Jaggupilli A; Elkord E
Clin Dev Immunol; 2012; 2012():708036. PubMed ID: 22693526
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-mediated CD24 expression is correlated with gastric cancer aggressiveness by promoting cell migration and invasion.
Fujikuni N; Yamamoto H; Tanabe K; Naito Y; Sakamoto N; Tanaka Y; Yanagihara K; Oue N; Yasui W; Ohdan H
Cancer Sci; 2014 Nov; 105(11):1411-20. PubMed ID: 25174257
[TBL] [Abstract][Full Text] [Related]
30. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.
Hurt EM; Kawasaki BT; Klarmann GJ; Thomas SB; Farrar WL
Br J Cancer; 2008 Feb; 98(4):756-65. PubMed ID: 18268494
[TBL] [Abstract][Full Text] [Related]
31. Association of human breast cancer CD44
Qiao X; Zhang Y; Sun L; Ma Q; Yang J; Ai L; Xue J; Chen G; Zhang H; Ji C; Gu X; Lei H; Yang Y; Liu C
Elife; 2021 Jul; 10():. PubMed ID: 34318746
[TBL] [Abstract][Full Text] [Related]
32. Association of CD44
Chekhun VF; Lukianova NY; Chekhun SV; Bezdieniezhnykh NO; Zadvorniy TV; Borikun TV; Polishchuk LZ; Klyusov OМ
Exp Oncol; 2017 Sep; 39(3):203-211. PubMed ID: 28967645
[TBL] [Abstract][Full Text] [Related]
33. CD44
Sihombing UHM; Andrijono A; Purwoto G; Gandamihardja S; Harahap AR; Rustamadji P; Kekalih A; Widyawati R; Fuady DR
J Egypt Natl Canc Inst; 2022 Oct; 34(1):44. PubMed ID: 36274112
[TBL] [Abstract][Full Text] [Related]
34. CD44+/CD24- cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breast.
Tiezzi DG; Valejo FA; Marana HR; Carrara HH; Benevides L; Antonio HM; Sicchieri RD; Milanezi CM; Silva JS; de Andrade JM
Med Oncol; 2012 Sep; 29(3):1479-85. PubMed ID: 21713550
[TBL] [Abstract][Full Text] [Related]
35. [Expression tumor stem cell surface marker CD44 in gastric cancer and its significance].
Xie JW; Huang CM; Zheng CH; Li P; Wang JB; Lin JX; Lu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1107-12. PubMed ID: 24277411
[TBL] [Abstract][Full Text] [Related]
36. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
Chen Y; Song J; Jiang Y; Yu C; Ma Z
Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
[TBL] [Abstract][Full Text] [Related]
37. CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival.
Meng E; Long B; Sullivan P; McClellan S; Finan MA; Reed E; Shevde L; Rocconi RP
Clin Exp Metastasis; 2012 Dec; 29(8):939-48. PubMed ID: 22610780
[TBL] [Abstract][Full Text] [Related]
38. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
39. Expression analysis of CD24 and CD44 transcripts in Iranian breast cancer patients.
Liaghati P; Momeni P; Esfandi F; Kholghi Oskooei V; Sattari A; Ghafouri-Fard S; Taheri M
Breast Dis; 2020; 39(3-4):143-148. PubMed ID: 33427725
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Significance of
Strati A; Nikolaou M; Georgoulias V; Lianidou ES
Cells; 2019 Jun; 8(7):. PubMed ID: 31261917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]